)
Green Cross Health (GXH) investor relations material
Green Cross Health H2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Group revenue increased 4% year-over-year to $546.0m, driven by improved medical funding, immunisation incentives, and higher pharmacy dispensary revenue.
Operating profit (EBIT) rose 17% to $45.3m, reflecting revenue growth and cost control initiatives.
Net profit after tax attributable to shareholders grew 28% to $20.4m, with EPS at 14.2 cps.
Final FY26 dividend of 5.50cps declared, payable on 22 June 2026, with a special dividend paid following the divestment of the Community Health division.
Digital enhancements included new apps and online booking systems for both Pharmacy and Medical divisions.
Financial highlights
Pharmacy operating revenue up 2% to $380.2m; operating profit up 4% to $22.2m.
Medical operating revenue up 8% to $165.8m; operating profit up 33% to $26.0m.
Over 38 million prescription items dispensed and 330,000 vaccinations administered, a 1% increase year-over-year.
Operating cash flow reached $54.6m; net cash position of $8.6m as of 31 March 2026.
Gearing ratio reduced to 9.4%; undrawn committed debt facilities of $46.0m.
Outlook and guidance
Launch of new Primary Health Organisation (Community Care Limited) set for 1 July 2026, strengthening direct funding and frontline services.
Expansion of Care & Advice Health Hubs and extension of pharmacist scope of practice expected to drive future growth.
Continued investment in technology, clinical services, targeted refurbishments, and operational efficiency to support revenue and margin growth.
Pharmacy to advocate for improved funding and expand Care & Advice Health Hubs.
- Revenue up, profit down; network and loyalty programme expanded, with ongoing investments.GXH
AGM presentation 2024 - Revenue and profit growth driven by acquisitions, innovation, and expanded clinical services.GXH
AGM presentation 2025 - Revenue up 2%, profit down 20% as inflation and lower COVID-19 activity hit margins.GXH
H2 2024 - Net profit after tax rose 27% on higher revenue, led by Medical Division gains and a higher dividend.GXH
H1 2026 - Revenue and profit rose as clinical services, digital innovation, and governance advanced.GXH
AGM 2025 - Revenue hit $523.8m, net profit $16.0m, and a 2.75c dividend was declared.GXH
H2 2025 - Revenue up 4% to $259.9m, profit and dividend rose, with strong medical segment growth.GXH
H1 2025
Next Green Cross Health earnings date
Next Green Cross Health earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)